About TIBET EASTMONEY FU
Expense ratio
0.55%
Home page
Inception date
Apr 21, 2023
CSI Shanghai-Hong Kong-Shenzhen Innovative Drug Industry Index - CNY - Benchmark TR Gross
ISIN
CNE100005YZ1
Tightly track the target index, pursue the minimization of tracking deviation and tracking err.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks98.48%
Health Technology94.23%
Commercial Services4.25%
Bonds, Cash & Other1.52%
Cash1.52%
Stock breakdown by region
Asia100.00%
North America0.00%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history